Skip to content
4 February 2022
BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature